Litlhaku tsa Phekolo ea Ramatiki ea Ramatiki

Litlhahiso tsa Tšebeliso ea DMARD le Litlhare tsa Biolotiki

Ka 2012, American College of Rheumatology (ACR) e ntlafalitse litlhahiso bakeng sa ho phekoloa ha ramatiki ea lefuba . Litlhahiso tsa ACR tsa 2012 bakeng sa tšebeliso ea lithethefatsi tse loantšang maloetse (DMARD) le mafu a biologic bakeng sa ramatiki ea lefuba ke tlhaloso ea likhoeletso tsa 2008.

Liphetoho tsa 2012 li lebisitsoe:

  1. lintlha tsa ho qala kapa ho fetola DMARD le lithethefatsi tsa biologic
  1. tšebeliso ea li-biologics e kotsing ea bakuli ba kotsing, ho kenyelletsa le ba nang le lefu la lefu la sebete, ho fokotsa pelo ea pelo, le ho bolaea batho
  2. Tlhahlobo ea lefuba bakeng sa bakuli ba qalang kapa hona joale ba nka lithethefatsi tsa biologic
  3. ho entoa ho bakuli ba qalang kapa hona joale ba nka DMARD kapa lithethefatsi tsa biolotiki

Litlhahiso tsena li ne li itšetlehile ka lipatlisiso tsa lingoliloeng tsa PubMed le Database ea Cochrane ea Tlhahlobo ea Ts'ebetso, tlhahlobo ea boemo ba tlhokomelo ea bongaka, le maikutlo a litsebi. Lingoliloeng li ile tsa batlisisoa ka li-DMARD tse 8: azathioprine (Imuran), cyclosporine , hydroxychloroquine (Plaquenil), leflunomide (Arava), methotrexate , minocycline (Minocin), khauta le sulfasalazine (Azulfidine) le lithethefatsi tse 9 tsa biologic: abatacept (Orencia) , adalimumab (Humira), anakinra (Kineret), segerike sekolo (Cimzia), etanercept (Enbrel), golimumab (Simponi), infliximab (Remicade), rituxab (Rituxan), leciliumumab (Actemra). Ka lebaka la tšebeliso e mpe ea lithethefatsi le ho hloka boitsebiso bo bocha bo fumanoeng lipatlisisong, azathioprine, cyclosporine, khauta le anakinra ha lia kenyelletsoa ho tsebiso.

Orencia, Rituxan, Kineret, le Actemra ke lithethefatsi tse seng tsa TNF tsa biologic. Enbrel, Remicade, Humira, Simponi, le Cimzia ke TNF blockers.

Bakeng sa bakuli ba nang le ramatiki ea lefu la pele (e hlalositsoeng e le lefu la ramatiki ea likhoeli tse ka tlaase ho 6) le bakuli ba nang le ramatiki ea lefuba ba tšoaroang ke leha e le efe DMARD kapa lithethefatsi tsa biologic, sepheo sa phekolo ke lefu le tlaase kapa le phoso.

Ho qala kapa ho fetola DMARD le Ditshebeletso tsa Biolotiki

Tšebeliso ea Biologics ho Rumatoid Arthritis Bakuli ba Nang le Lefu la Sefu, Malignancy, kapa ho Hlōleha ha Pelo ea Lelapa

Sefuba (TB) Ho hlahloba

Liente bakeng sa bakuli Ho qala kapa ho fumana DMARD kapa Likokoana-hloko tsa Bioloki

SEHLOOHO - 2015 MELAO ea ACR ea ho Phekola Ramatiki ea Ramatiki

Lataelo li ile tsa boela tsa phatlalatsoa ka 2015 e le tlhahiso ea tataiso ea 2012. Tataiso ea 2015 e akaretsa tšebeliso ea lithethefatsi tse tloaelehileng tsa ho loantša mafu (DMARD), mahlaseli a biologic, Xeljanz (tofacitinib) , le glucocorticoids mathoasong (likhoeli tse ka tlase ho likhoeli tse tšeletseng) le ho thehoa (likhoeli tse 6 kapa ho feta) lefu la ramatiki. E boetse e fanoe ka tataiso ea 2015 ke litlhahiso tsa ho sebelisa mokhoa oa ho phekola , ho khaola le ho khaotsa meriana, le tšebeliso ea lihlahisoa tsa biologic le DMARD ho bakuli ba nang le lefu la lefu la sebete, ho fokolloa ke pelo, ho bolaoa ke mafu le mafu a tebileng.

Tataiso e bua ka tšebeliso ea liente ho bakuli ba qalang kapa ba amohelang DMARD kapa lithethefatsi tsa biologic, ho hlahloba lefuba ho bakuli ba qalang kapa ba amohelang mahlahana a biologic kapa tofacitinib, le ho hlahloba lipatlisiso bakeng sa DMARD tsa setso. Moelelo ona o kenyelletsa likhothaletso tse 74 tseo 23% li nkoang li le matla 'me 77% li na le maemo. U ka e fumana mona: 2015 College of American Rheumatology Guideline bakeng sa Phekolo ea Ramatiki ea Ramatiki.

Mohloli:

Phetoho ea Likhakanyo tsa ACR tsa 2008 bakeng sa Tšebeliso ea DMARD le Biologics ho Phekolo ea Ramatiki ea Ramatiki. Tlhokomelo ea Ramatiki le Lipatlisiso. maq. 625-639. Singh JA le al. May 2012.
http://onlinelibrary.wiley.com/doi/10.1002/acr.21641/abstract

2015 American College of Rheumatology Guideline bakeng sa Phekolo ea Rheumatoid Arthritis Singh JA et al. Tlhokomelo ea Ramatiki le Lipatlisiso DOI 10.1002 / acr.22783
http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf